Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay Read more about Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
Outcomes in oncogenic-addicted advanced NSClC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay Read more about Outcomes in oncogenic-addicted advanced NSClC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types Read more about Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma Read more about Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy Read more about Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy
Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer Read more about Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer